CARDIAC CATH LAB - Mount Sinai Hospital

PCI cases as among the lowest in the state
and about 30 percent lower than the
statewide average. A big part of this lower
30-day risk-adjusted mortality is due to the
experience and high volume of the senior
attending full-time interventionalists. In
the 2006 report, Dr. Annapoorna Kini
was awarded the double-star notation,
denoting significantly lower 30-day riskadjusted
mortality among approximately
450 interventionalists practicing in NY State.
The numbers of both medical
and nonmedical cath lab staff
have grown tremendously to
accomplish the ultimate goal
of delivering the safest and
highest-quality care.
• Clinical Research: In addition to achieving
clinical success, the cath lab has participated
in numerous investigator-initiated and
multi-center trials in the field of coronary
interventions. Many of these endeavors have
resulted in FDA approval of new drugs and
devices to improve the outcome and safety
of percutaneous interventional procedures.
Also, key scientific publications on various
PCI outcomes from our vast interventional
database repository of approximately 30,000
patients since 2000 continue to advance the
field of interventional cardiology in a safe
and progressive manner. Five research
coordinators and five database coordinators
are constantly engaged in recruiting patients
for research trials and obtaining detailed and
comprehensive follow-up of all interventional
patients (in-hospital, at 30 days and one year).
• Cath Lab Staff: To effectively manage
increasing volume, extreme pressure is
placed on both physical infrastructure and
the cath lab staff. The numbers of both
medical and nonmedical cath lab staff
have grown tremendously to accomplish
the ultimate goal of delivering the safest
and highest-quality care. Presently there are
6 Mount Sinai Hospital Cardiac Cath Lab